Showing results (531-540 of 654) with videos related to

Sort By:
Pageof 66
The Lancet. Planetary Health|April 5, 2024
Ambient heat exposure and kidney function in patients with chronic kidney disease: a post-hoc analysis of the DAPA-CKD trialZhiyan Zhang, Hiddo J L Heerspink, Glenn M Chertow, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 2, 2009
Development and validation of GFR-estimating equations using diabetes, transplant and weightLesley A Stevens, Christopher H Schmid, Yaping L Zhang, et al.
NEJM Evidence|February 6, 2024
Dapagliflozin and Anemia in Patients with Chronic Kidney DiseaseAkihiko Koshino, Meir Schechter, Glenn M Chertow, et al.
The New England Journal of Medicine|September 24, 2020
Dapagliflozin in Patients with Chronic Kidney DiseaseHiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, et al.
Kidney Medicine|September 25, 2023
Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY AnalysisSylvia E Rosas, Luis M Ruilope, Stefan D Anker, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 18, 2026
Kidney and Survival Outcomes with Semaglutide by Chronic Kidney Disease Severity in the FLOW TrialKatherine R Tuttle, Johannes F E Mann, Manuel M Mayrdorfer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 17, 2016
Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysisJustyna Siwy, Petra Zürbig, Angel Argiles, et al.
Journal of the American College of Cardiology|September 1, 2024
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW TrialRichard E Pratley, Katherine R Tuttle, Peter Rossing, et al.
Pageof 66